In 2030, there is a boom in precision medicine, where diseases – from cancer to dementia – are defined and targeted more specifically with a focus on their molecular makeup.
Articles on Rare diseases
Displaying 21 - 33 of 33 articles
Specialty prescription drugs are responsible for countless medical miracles, but their high price tag is the main reason health care costs are out of control.
Rare diseases may only affect a handful of people but their treatment benefits everyone.
Children’s cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
Policy moves to benefit patients are now benefiting business.
Gigantism and acromegaly are rare conditions where a benign tumour causes excessive production of growth hormone (GH), which stimulates the growth of the skeleton and all tissues in the body.
Rare diseases are yielding secrets about very common conditions.
By definition, a rare disease isn’t always easy to spot but there are ways to make it easier to do.
Some things that develop as normal in elephant sharks and other marine life can mimic things we see in human disease. That makes these ‘mutants’ ideal for study to find out why things go wrong in humans.
There is a high prevalence of the MERS virus in African camels. More research is key to understanding the virus better globally.
Researchers have found that mexiletine, an anti-arrhythmic medication now rarely prescribed, is effective at easing pain…
Patients with the rare genetic disorder X-linked lymphoproliferative disease (XLP) are in some cases living longer thanks…
Encephalitis lethargica, an infectious disorder that only once appeared in epidemic form (1916-1926), is largely forgotten now. But this curious illness provided significant insights into brain function…
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Anatomy, Lancaster University
-
Professor of Microbiology and Immunology, Indiana University
-
Research Fellow, Cardiff University
-
Professor of Pharmacoeconomics, Co-director of the Centre for Health Economics & Medicines Evaluation, Bangor University
-
Associate Professor (conjoint), Children's Cancer Institute
-
John Curtin Distinguished Professor, Molecular and Life Sciences, Curtin University
-
Professor, Central Clinical School, Monash University
-
Professor, The University of Queensland
-
Researcher and Head of Division in Earth Sciences, Natural History Museum
-
Senior Lecturer in Accounting and Finance, University of Liverpool
-
Senior Research Fellow, Neuroscience Research Australia
-
Professor, Children's Cancer Institute
-
Associate Professor of Neurology, UMass Chan Medical School
-
Curtin Research Fellow, Curtin University